Varenicline Kit
Product Images NDC 67877-745

9 FDA label images from Ascend Laboratories, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Varenicline (NDC 67877-745). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Var01 (Var01)

Var01 (Var01)
Chemical structure diagram showing the molecular composition of varenicline tartrate, the active ingredient in varenicline tablets. The illustration includes the structural formula with atom symbols and bonds representing the compound.*
FDA Label Image

Var-fig-1 (Var Fig 1)

Var-fig-1 (Var Fig 1)
A bar chart presenting comparative data from five studies evaluating varenicline and bupropion treatments versus placebo. The vertical axis shows percentages from 0% to 60%. The horizontal axis categorizes results by study number and treatment type, including varenicline 0.5 mg BID, varenicline 1.0 mg BID, varenicline flexible dosing, bupropion SR 150 mg BID, and placebo. Bars represent outcome measures with error bars indicating variability.*
FDA Label Image

Var-fig-2 (Var Fig 2)

Var-fig-2 (Var Fig 2)
A bar chart comparing the percentage outcomes of varenicline 0.5 mg BID, varenicline 1.0 mg BID, bupropion 150 mg BID, and placebo across four separate studies labeled Study 2, Study 3, Study 4, and Study 5. Each study displays bars with percentage values on the vertical axis and includes error bars representing variability.*
FDA Label Image

Var04 (Var04)

Var04 (Var04)
A line graph comparing the percentage of continuous abstinent individuals over weeks of nontreatment follow-up for varenicline tablets 1.0 mg BID versus placebo. The y-axis shows percentage abstinent, and the x-axis shows follow-up time in weeks. The varenicline group maintains a higher abstinence percentage than placebo throughout the period.*
FDA Label Image

Var051-1a (Var051 1a)

Var051-1a (Var051 1a)
Packaging label for Varenicline Tablets Starting Pack by Ascend Laboratories, LLC. The label shows a blister card with a green Starting Week section containing 0.5 mg tablets and blue Continuing Week sections containing 1 mg tablets. The pack includes instructions for use, dosage details, storage information, and the NDC 67877-745-54.*
FDA Label Image

Var-cart (Var Cart)

Var-cart (Var Cart)
Packaging label for Varenicline Tablets Starting Month Box by Ascend Laboratories, LLC. The label specifies two tablet strengths: 0.5 mg and 1 mg film-coated tablets. It includes directions for use over four weeks with an initial week of 0.5 mg tablets followed by three weeks of 1 mg tablets. Manufactured by Alkem Laboratories, Ltd, the box is identified by NDC 67877-745-54 and is labeled Rx Only.*
FDA Label Image

Var071-1a (Var071 1a)

Var071-1a (Var071 1a)
Packaging label for Varenicline Tablets 1 mg oral film-coated tablets in a continuing pack of 56 tablets (4 continuing weeks) by Ascend Laboratories, LLC. The label includes instructions for use, storage directions, and dosage information. It also shows a calendar blister pack for dosing schedule.*
FDA Label Image

Var-05mg-56s-cont (Var 05mg 56s Cont)

Var-05mg-56s-cont (Var 05mg 56s Cont)
Packaging label for Varenicline Tablets 0.5 mg, film-coated oral tablets. The label indicates storage instructions, dosage information, and manufacturer details, including Ascend Laboratories, LLC as distributor. The package contains 56 tablets and is prescription only. The label also includes barcodes and instructions for batch details and a 2D code.*
FDA Label Image

Var-1mg-56s-cont (Var 1mg 56s Cont)

Var-1mg-56s-cont (Var 1mg 56s Cont)
The packaging label for Varenicline Tablets 1 mg film-coated oral tablets by Ascend Laboratories, LLC. The label states the NDC 67877-744-95 and contains 56 tablets. It includes storage instructions, manufacturing and distribution details, and a barcode. There is also an area designated for batch details and a 2D code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.